Unpacking Substance Use: Mono vs. Polysubstance Patterns and More
Episode Overview
64% reported monouse among those who used at least one substance in the last year Research should include those with polysubstance use whenever possible Methamphetamine and heroin co-use patterns and motives revealed Cytosinicline's efficacy and tolerability for smoking cessation Barriers to treatment for Ukrainian refugees with opioid use disorder
Research should include those with polysubstance use whenever possible, and consideration of polysubstance use should be part of critical evaluations and treatment.
Ever wondered why most addiction studies focus on single substances rather than the more complex reality of polysubstance use? In this thought-provoking episode of 'This Week in Addiction Medicine', Claire Rasmussen sheds light on a pivotal study examining the prevalence of mono- versus polysubstance use in the general population. The findings reveal that while the majority of users report mono-use, predominantly alcohol, those with substance use disorders often engage in polysubstance use.
This challenges the traditional focus on single drug classifications and calls for a broader perspective in both research and treatment evaluations. But that's not all. The episode dives into methamphetamine and heroin co-use patterns, uncovering diverse motives and methods among users. It also explores a randomized clinical trial on cytisinicline for smoking cessation, providing insights into its effectiveness and tolerability.
Additionally, Claire addresses the significant barriers faced by Ukrainian refugees with opioid use disorder in accessing maintenance therapies, highlighting the need for better utilization of provider networks. Whether you're a healthcare professional, a student, or someone touched by addiction, this episode offers valuable knowledge and fresh perspectives. Tune in to understand the complexities of substance use and stay informed about the latest breakthroughs and challenges in addiction medicine.